Hostname: page-component-8448b6f56d-sxzjt Total loading time: 0 Render date: 2024-04-19T23:30:35.410Z Has data issue: false hasContentIssue false
  • English
  • Français

Controlling Use of Antimicrobial Agents

Published online by Cambridge University Press:  02 January 2015

Loreen A. Herwaldt  and
Robert A. Duncan
Loreen A. Herwaldt
Affiliation:
Section of Infectious Diseases, Department of Internal Medicine, Lahey Hitchcock Clinic, Burlington, Massachusetts
Robert A. Duncan
Affiliation:
Section of Infectious Diseases, Department of Internal Medicine, Lahey Hitchcock Clinic, Burlington, Massachusetts
Get access Rights & Permissions [Opens in a new window]

Abstract

Physicians and hospitals must curtail the excessive use of antimicrobial agents to limit the emergence and spread of multiply resistant organisms. This article describes how to organize an antimicrobial control program and provides options for hospitals working with a range of resources.

Type
Practical Healthcare Epidemiology
Information
Infection Control & Hospital Epidemiology , Volume 18 , Issue 4 , April 1997 , pp. 260 - 266
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Kunin, CM. Problems in antibiotic usage. In: Mandell, GL, Douglas, RG, Bennett, JE, eds. Principles and Practice of Infectious Diseases. 3rd ed. New York, NY: Churchill Livingstone; 1990:427–434.Google Scholar
2.McGowan, JE Jr. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983;5:1033–1048.Google Scholar
3.Tomasz, A. Multiple-antibiotic agent-resistant pathogenic bacteria: a report on the Rockefeller University Workshop. N Engl J Med 1994;330:1247–1251.Google Scholar
4.Neu, HC. The crisis in antibiotic resistance. Science 1992;257:1064–1073.Google Scholar
5.Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance. Guidelines for the prevention of antimicrobial resistance in hospitals: a report from the Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance. Infect Control Hosp Epidemiol 1997;18:275–291.Google Scholar
6.Goldmann, DA, Weinstein, RA, Wenzel, RP, et al. Strategies to prevent and control the emergence and spread of antimicrobialresistant microorganisms in hospitals: a challenge to hospital leadership. JAMA 1996;275:234–240.Google Scholar
7.Marr, JJ, Moffet, HL, Kunin, CM. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. J Infect Dis 1988;157:869–876.Google Scholar
8.McGowan, JE Jr. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol 1994;15:478–483.Google Scholar
9.Bryan, CS. Strategies to improve antibiotic use. Infect Dis Clin North Am 1989;3:723–734.Google Scholar
10.Kunin, CM. The responsibility of the infectious disease community for the optimal use of antimicrobial agents. J Infect Dis 1985;3:388–398.Google Scholar
11.Blaser, J, Koenig, C. Once-daily dosing of aminoglycosides. European Journal of Microbiology and Infectious Disease 1995;14:1029–1038.Google Scholar
12.Gilbert, DN. Once-daily aminoglycoside therapy. Antimicrob Agents Chemother 1991;35:399–405.Google Scholar
13.Nightingale, CH, Quintiliani, R, Nicolau, DP. Intelligent dosing of antimicrobials. Current Clin Top Infect Dis 1994;14:252–265.Google Scholar
14.Duncan, RA, Segarra, M, Anderson, ER, Chow, LS, Needham, C, Jacoby, GA. A comprehensive approach to reforming therapeutic antibiotic (ABx) use. Infect Control Hosp Epidemiol 1995;16(suppl):37. Abstract M7.Google Scholar
15.Evans, RS, Classen, DC, Pestotnik, SL, Lundsgaarde, HP, Burke, JP. Improving empiric antibiotic selection using computer decision support. Arch Intern Med 1994;154:878–884.Google Scholar
16.Pestotnik, SL, Evans, RS, Burke, JP, et al. Therapeutic antibiotic monitoring: surveillance using a computerized expert system. Am J Med 1990;88:43–48.Google Scholar
17.Pestotnik, SL, Classen, DC, Evans, RS, Burke, JP. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med 1996;124:884–890.Google Scholar
18.Monnet, D. Relationship between antibiotic resistance and antibiotic use. Proceedings of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy; San Francisco, CA; 09 17-20, 1995. Abstract S21.Google Scholar
19.Monnet, D, Gaynes, R, Tenover, F, McGowan, J, ICARE pilot hospitals. Ceftazidime-resistant Pseudomonas aeruginosa (PA) and ceftazidime (CFZ) usage in NNIS hospitals: preliminary results of project ICARE phase one. Infect Control Hosp Epidemiol 1995;16;4(suppl):19. Abstract 22.Google Scholar